Beneficial ownership — 13D / 13G
87,387 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | PBK POWERBANK Corp | 13G/A | 4.9% | Mar 31, 2026 | 6mo |
| Westchester Capital Management, LLC | PACH Pioneer Acquisition I Corp | 13G | 5.65% | Mar 31, 2026 | 6mo |
| Juniper Capital III GP, L.P. | BTE Baytex Energy Corp. | 13G/A | 5.29% | Mar 31, 2026 | 6mo |
| STEADFAST CAPITAL MANAGEMENT LP | PLNT Planet Fitness, Inc. | 13G/A | 2.8% | Mar 31, 2026 | 6mo |
| First Trust Capital Management L.P. | MRLN Merlin, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | WWW Wolverine World Wide Inc | 13G | 5.3% | Mar 31, 2026 | 6mo |
| T. Rowe Price Investment Management, Inc. | IMTX Immatics N.V. | 13G/A | 16.1% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | GWHTQ ESS Tech, Inc. | 13G/A | 5.15% | Mar 31, 2026 | 6mo |
| Gates Capital Management, Inc. | TIC TIC Solutions, Inc. | 13G/A | 9.9% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | KPRX Kiora Pharmaceuticals Inc | 13G | 9.99% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | DNTH Dianthus Therapeutics, Inc. | 13G | 5.3% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | XENE Xenon Pharmaceuticals Inc. | 13G/A | 4.5% | Mar 31, 2026 | 6mo |
| BAMCO INC /NY/ | STVN Stevanato Group S.p.A. | 13G | 5.03% | Mar 31, 2026 | 6mo |
| Wellington Trust Company, NA | MNTN MNTN, Inc. | 13G/A | 4.7% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | IDYA IDEAYA Biosciences, Inc. | 13G/A | 8.3% | Mar 31, 2026 | 6mo |
| AQR CAPITAL MANAGEMENT LLC | EIX Edison International | 13G | 5.41% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | GIL Gildan Activewear Inc. | 13G/A | 5.7% | Mar 31, 2026 | 6mo |
| COOPER CREEK PARTNERS MANAGEMENT LLC | GSM Ferroglobe PLC | 13G/A | 7.3% | Mar 31, 2026 | 6mo |
| Redmile Group, LLC | ALXO Alx Oncology Holdings Inc | 13G/A | 6.8% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | BHAV BHAV Acquisition Corp | 13G | 7.9% | Mar 31, 2026 | 6mo |
| TORONTO DOMINION BANK | URGN UroGen Pharma Ltd. | 13G | 5.4% | Mar 31, 2026 | 6mo |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | NRDS Nerdwallet, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| STEMPOINT CAPITAL LP | FTH Faeth Therapeutics, Inc. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| ARMISTICE CAPITAL, LLC | AEMD Aethlon Medical Inc | 13G/A | 4.99% | Mar 31, 2026 | 6mo |
| Alyeska Investment Group, L.P. | FTW PRESIDIO PRODUCTION Co | 13G | 9.8% | Mar 31, 2026 | 6mo |
| STATE OF WISCONSIN INVESTMENT BOARD | EMF Templeton Emerging Markets Fund | 13G/A | 4.35% | Mar 31, 2026 | 6mo |
| JANUS HENDERSON GROUP PLC | PCVX Vaxcyte, Inc. | 13G/A | 11.5% | Mar 31, 2026 | 6mo |
| Encompass Capital Advisors LLC | NESR National Energy Services Reunited Corp. | 13G/A | 4.23% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | SE Sea Ltd | 13G | 6.1% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | ENHA Enhanced Group Inc. | 13G | 0% | Mar 31, 2026 | 6mo |
| Commodore Capital LP | LBRX Lb Pharmaceuticals Inc | 13G/A | 6.8% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | TNXP Tonix Pharmaceuticals Holding Corp. | 13G | 8.8% | Mar 31, 2026 | 6mo |
| PRICE T ROWE ASSOCIATES INC /MD/ | CRNX Crinetics Pharmaceuticals, Inc. | 13G/A | 5.1% | Mar 31, 2026 | 6mo |
| WELLINGTON MANAGEMENT GROUP LLP | FRPT Freshpet, Inc. | 13G | 5.2% | Mar 31, 2026 | 6mo |
| G1 Execution Services, LLC | LAES SEALSQ Corp | 13G/A | 5.4% | Mar 31, 2026 | 6mo |
| TCG Crossover GP II, LLC | FULC Fulcrum Therapeutics, Inc. | 13G/A | 7.9% | Mar 31, 2026 | 6mo |
| GENDELL JEFFREY L | BXC BlueLinx Holdings Inc. | 13G/A | 9.4% | Mar 31, 2026 | 6mo |
| Keith Crandell | MASS 908 Devices Inc. | 13G/A | 15.3% | Mar 31, 2026 | 6mo |
| MORGAN STANLEY | FTW PRESIDIO PRODUCTION Co | 13G | 6.2% | Mar 31, 2026 | 6mo |
| Divesh Makan | OWL Blue Owl Capital Inc. | 13G/A | 5.1% | Mar 31, 2026 | 6mo |
| METEORA CAPITAL, LLC | CEPT Cantor Equity Partners II, Inc. | 13G/A | 0% | Mar 31, 2026 | 6mo |
| Commodore Capital LP | PEPG PepGen Inc. | 13G/A | 6.5% | Mar 31, 2026 | 6mo |
| Sirenia Capital Management LP | XLO Xilio Therapeutics, Inc. | 13G | 9.9% | Mar 31, 2026 | 6mo |
| G1 Execution Services, LLC | HIMS Hims & Hers Health, Inc. | 13G | 6.5% | Mar 31, 2026 | 6mo |
| Nantahala Capital Management, LLC | GUTS Fractyl Health, Inc. | 13G/A | 9.99% | Mar 31, 2026 | 6mo |
| BAMCO INC /NY/ | RRR Red Rock Resorts, Inc. | 13G/A | 22.68% | Mar 31, 2026 | 6mo |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | BELFA Bel Fuse Inc | 13G | 6.5% | Mar 31, 2026 | 6mo |
| Balyasny Asset Management L.P. | OVID Ovid Therapeutics Inc. | 13G | 5.33% | Mar 31, 2026 | 6mo |
| Rubric Capital Management LP | EPC EDGEWELL PERSONAL CARE Co | 13G | 8.56% | Mar 31, 2026 | 6mo |
| Polar Asset Management Partners Inc. | TAVI Tavia Acquisition Corp. | 13G/A | 8.3% | Mar 31, 2026 | 6mo |